Key result
Salivary exosomes show promise as non-invasive biomarkers for early CVD detection and monitoring.
Why the study?
Cardiovascular disease remains the leading cause of mortality worldwide, necessitating innovative diagnostic approaches due to the limitations of current diagnostic tools.
This narrative review highlights the emerging potential of salivary exosomes as non-invasive biomarkers for the early detection, risk stratification, and monitoring of cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
May support non-invasive salivary exosome analysis for CVD monitoring; leaves open prospective validation before clinical adoption.
Cardiovascular disease (CVD) is the primary cause of mortality world wide, necessitating innovative diagnostic approaches due to the limitations of current tools. The growing significance of salivary exosomes as biomarkers for CVD detection and treatment is explored in this narrative review. Salivary diagnostics offer a non-invasive alternative, with exosomes-small extracellular vesicles containing proteins, lipids, and nucleic acids—serving as potential indicators of cardiovascular health. The review highlights how salivary exosomes reflect the physiological states of their parent cells and can indicate systemic inflammation, oxidative stress, and endothelial dysfunction, all critical factors in CVD progression. Furthermore, it discusses specific exosomal biomarkers linked to different cardiovascular diseases such as valvular heart disease, coronary artery disease, cardiac fibrosis, arrhythmias, and heart failure. By integrating salivary exosome analysis into clinical practice, there is potential for enhanced early detection, risk stratification, and monitoring of cardiovascular diseases, ultimately paving the way for more personalized treatment strategies. This exploration underscores the transformative potential of salivary exosomes in improving cardiovascular disease management and patient outcomes.
No takes yet. Share an insight, caveat, or question.
A 2025 study conducted a review in Cardiovascular disease. Salivary exosomal biomarkers was evaluated. Salivary exosomes containing specific microRNAs and other bioactive molecules offer a promising non-invasive diagnostic approach for the early detection and monitoring of cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: